Literature DB >> 33127377

Skin substitutes for the treatment of chronic wounds in patients with cancer: A retrospective case series.

Joseph R Stoll1, Sarah J Noor2, Stephen W Dusza1, Alina Markova3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33127377      PMCID： PMC8485225          DOI： 10.1016/j.jaad.2020.10.064

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  The burden of skin disease in the United States.

Authors:  Henry W Lim; Scott A B Collins; Jack S Resneck; Jean L Bolognia; Julie A Hodge; Thomas A Rohrer; Marta J Van Beek; David J Margolis; Arthur J Sober; Martin A Weinstock; David R Nerenz; Wendy Smith Begolka; Jose V Moyano
Journal:  J Am Acad Dermatol       Date:  2017-03-01       Impact factor: 11.527

2.  Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.

Authors:  Ladan Afifi; Isabelle M Sanchez; Matthew M Wallace; Sara F Braswell; Alex G Ortega-Loayza; Kanade Shinkai
Journal:  J Am Acad Dermatol       Date:  2017-12-27       Impact factor: 11.527

3.  Cost-of-illness studies in chronic ulcers: a systematic review.

Authors:  B Chan; S Cadarette; W Wodchis; J Wong; N Mittmann; M Krahn
Journal:  J Wound Care       Date:  2017-04-01       Impact factor: 2.072

4.  Cyclosporine induces cancer progression by a cell-autonomous mechanism.

Authors:  M Hojo; T Morimoto; M Maluccio; T Asano; K Morimoto; M Lagman; T Shimbo; M Suthanthiran
Journal:  Nature       Date:  1999-02-11       Impact factor: 49.962

Review 5.  Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.

Authors:  C Barber; A Watt; C Pham; K Humphreys; A Penington; K Mutimer; M Edwards; G Maddern
Journal:  J Wound Care       Date:  2008-12       Impact factor: 2.072
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.